BSL: A Unified and Generalizable Multitask Learning Platform for Virtual Drug Discovery from Design to Synthesis

• URL: http://arxiv.org/abs/2508.01195v1
• Date: Sat, 02 Aug 2025 04:58:56 GMT
• Title: BSL: A Unified and Generalizable Multitask Learning Platform for Virtual Drug Discovery from Design to Synthesis
• Authors: Kun Li, Zhennan Wu, Yida Xiong, Hongzhi Zhang, Longtao Hu, Zhonglie Liu, Junqi Zeng, Wenjie Wu, Mukun Chen, Jiameng Chen, Wenbin Hu,
• Abstract summary: We propose Bailaisheng (BSL), a deep learning-enhanced, open-access platform designed for virtual drug discovery.<n>BSL integrates seven core tasks within a unified and modular framework, incorporating advanced technologies such as generative models and graph neural networks.<n>BSL offers both algorithmic innovation and high-precision prediction for real-world pharmaceutical research.
• Score: 12.52676269708914
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug discovery is of great social significance in safeguarding human health, prolonging life, and addressing the challenges of major diseases. In recent years, artificial intelligence has demonstrated remarkable advantages in key tasks across bioinformatics and pharmacology, owing to its efficient data processing and data representation capabilities. However, most existing computational platforms cover only a subset of core tasks, leading to fragmented workflows and low efficiency. In addition, they often lack algorithmic innovation and show poor generalization to out-of-distribution (OOD) data, which greatly hinders the progress of drug discovery. To address these limitations, we propose Baishenglai (BSL), a deep learning-enhanced, open-access platform designed for virtual drug discovery. BSL integrates seven core tasks within a unified and modular framework, incorporating advanced technologies such as generative models and graph neural networks. In addition to achieving state-of-the-art (SOTA) performance on multiple benchmark datasets, the platform emphasizes evaluation mechanisms that focus on generalization to OOD molecular structures. Comparative experiments with existing platforms and baseline methods demonstrate that BSL provides a comprehensive, scalable, and effective solution for virtual drug discovery, offering both algorithmic innovation and high-precision prediction for real-world pharmaceutical research. In addition, BSL demonstrated its practical utility by discovering novel modulators of the GluN1/GluN3A NMDA receptor, successfully identifying three compounds with clear bioactivity in in-vitro electrophysiological assays. These results highlight BSL as a promising and comprehensive platform for accelerating biomedical research and drug discovery. The platform is accessible at https://www.baishenglai.net.

Related papers

• VitaGraph: Building a Knowledge Graph for Biologically Relevant Learning Tasks [8.962235896860294]
  We present a comprehensive biological knowledge graph constructed by integrating and refining multiple publicly available datasets.<n>The resulting resource represents a coherent and reliable biological knowledge graph that serves as a state-of-the-art platform to advance research in computational biology and precision medicine.
  arXiv  Detail & Related papers  (2025-05-16T12:43:04Z)
• AI-Powered Prediction of Nanoparticle Pharmacokinetics: A Multi-View Learning Approach [5.912585771981805]
  Existing AI-driven approaches rely on AI-driven predictions but fail to learn about NP properties.<n>This work lays the foundation for data-efficient AI-driven drug discovery and precision nanomedicine.
  arXiv  Detail & Related papers  (2025-03-18T01:09:32Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• ProBio: A Protocol-guided Multimodal Dataset for Molecular Biology Lab [67.24684071577211]
  The challenge of replicating research results has posed a significant impediment to the field of molecular biology. We first curate a comprehensive multimodal dataset, named ProBio, as an initial step towards this objective. Next, we devise two challenging benchmarks, transparent solution tracking and multimodal action recognition, to emphasize the unique characteristics and difficulties associated with activity understanding in BioLab settings.
  arXiv  Detail & Related papers  (2023-11-01T14:44:01Z)
• Machine Learning for Uncovering Biological Insights in Spatial Transcriptomics Data [0.0]
  Development and homeostasis in multicellular systems require exquisite control over spatial molecular pattern formation and maintenance. Advances in spatial transcriptomics (ST) have led to rapid development of innovative machine learning (ML) tools. We summarize major ST analysis goals that ML can help address and current analysis trends.
  arXiv  Detail & Related papers  (2023-03-29T14:22:08Z)
• Interpretability from a new lens: Integrating Stratification and Domain knowledge for Biomedical Applications [0.0]
  This paper proposes a novel computational strategy for the stratification of biomedical problem datasets into k-fold cross-validation (CVs) This approach can improve model stability, establish trust, and provide explanations for outcomes generated by trained IML models.
  arXiv  Detail & Related papers  (2023-03-15T12:02:02Z)
• Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey [6.288056740658763]
  Graph Machine Learning (GML) has gained considerable attention for its exceptional ability to model graph-structured biomedical data. Recent studies have proposed integrating external biomedical knowledge into the GML pipeline to realise more precise and interpretable drug discovery.
  arXiv  Detail & Related papers  (2023-02-16T12:38:01Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• DrugOOD: Out-of-Distribution (OOD) Dataset Curator and Benchmark for AI-aided Drug Discovery -- A Focus on Affinity Prediction Problems with Noise Annotations [90.27736364704108]
  We present DrugOOD, a systematic OOD dataset curator and benchmark for AI-aided drug discovery. DrugOOD comes with an open-source Python package that fully automates benchmarking processes. We focus on one of the most crucial problems in AIDD: drug target binding affinity prediction.
  arXiv  Detail & Related papers  (2022-01-24T12:32:48Z)
• Machine Learning in Nano-Scale Biomedical Engineering [77.75587007080894]
  We review the existing research regarding the use of machine learning in nano-scale biomedical engineering. The main challenges that can be formulated as ML problems are classified into the three main categories. For each of the presented methodologies, special emphasis is given to its principles, applications, and limitations.
  arXiv  Detail & Related papers  (2020-08-05T15:45:54Z)
• Uncovering the structure of clinical EEG signals with self-supervised learning [64.4754948595556]
  Supervised learning paradigms are often limited by the amount of labeled data that is available. This phenomenon is particularly problematic in clinically-relevant data, such as electroencephalography (EEG) By extracting information from unlabeled data, it might be possible to reach competitive performance with deep neural networks.
  arXiv  Detail & Related papers  (2020-07-31T14:34:47Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.